SCHEMBL5147476

SCHEMBL5147476

Cc1cc(-c2nc(NCCN3C(=O)NC(C)(C)C3=O)ncc2-c2cccc(O)c2)sc1-c1cccc(O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
RAF1 P04049 9/20 0.37
BRAF P15056 9/20 0.37
ADORA1 P30542 3/20 0.35
ERN1 O75460 1/20 0.34
ABL1 P00519 1/20 0.34
FGFR1 P11362 1/20 0.34
FLT3 P36888 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
NTRK2 Q16620 1/20 0.34
HIPK1 Q86Z02 1/20 0.34
MAP3K20 Q9NYL2 1/20 0.34
EGFR P00533 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDR P35968 1/20 0.32
PLK1 P53350 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149006 0.92 ADORA1 (0.39) RAF1BRAFADORA1ERN1ABL1
SCHEMBL5145850 0.88 HSD17B1 (0.38) HSD17B1HSD17B2RAF1BRAFADORA1
SCHEMBL5147347 0.88 ADORA1 (0.38) RAF1BRAFADORA1ERN1ABL1
SCHEMBL2980178 0.87 HSD17B1 (0.40) HSD17B1HSD17B2RAF1BRAFADORA1
SCHEMBL5149101 0.85 RAF1 (0.37) RAF1BRAFADORA1ERN1ABL1
SCHEMBL5145972 0.81 RAF1 (0.39) RAF1BRAFERN1ABL1FGFR1
SCHEMBL5148381 0.80 BRAF (0.39) HSD17B1HSD17B2RAF1BRAFERN1
SCHEMBL2984465 0.78 ADORA1 (0.39) RAF1BRAFADORA1ERN1ABL1
SCHEMBL5147378 0.78 ADORA1 (0.40) ADORA1ABL1FGFR1MAPK14EGFR
SCHEMBL5147429 0.77 ADORA1 (0.37) BRAFADORA1ABL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed